Published in Exp Dermatol on June 01, 2006
Mosquito saliva serine protease enhances dissemination of dengue virus into the mammalian host. J Virol (2013) 1.05
Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany. Cell Mol Life Sci (2011) 1.02
Development of an ex vivo human skin model for intradermal vaccination: tissue viability and Langerhans cell behaviour. Vaccine (2009) 0.92
Perspectives on Non-Animal Alternatives for Assessing Sensitization Potential in Allergic Contact Dermatitis. Cell Mol Bioeng (2012) 0.78
Histone H3 Phosphorylation in Human Skin Histoculture as a Tool to Evaluate Patient's Response to Antiproliferative Drugs. Biomark Insights (2016) 0.75
Role of marker lesion when applying intravesical instillations of IL-2 for non-muscle-invasive bladder cancer comparison of the therapeutic effects in two pilot studies. Anticancer Res (2013) 1.93
Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo. Lab Invest (2003) 1.41
Therapeutic implications of autoimmune vitiligo T cells. Autoimmun Rev (2006) 1.12
Functional defects of dendritic cells in patients with CD40 deficiency. Blood (2003) 1.02
Autoimmune aspects of depigmentation in vitiligo. J Investig Dermatol Symp Proc (2004) 1.01
Melanocyte-specific immune response in melanoma and vitiligo: two faces of the same coin? Pigment Cell Res (2003) 0.93
Local therapy of cancer with free IL-2. Cancer Immunol Immunother (2008) 0.93
Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. European Cosmetic, Toiletry and Perfumery Association. Food Chem Toxicol (1999) 0.90
In vitro and in vivo protein delivery from in situ forming poly(ethylene glycol)-poly(lactide) hydrogels. J Control Release (2007) 0.88
"First do no harm" and the importance of prediction in oncology. EPMA J (2010) 0.86
In situ crosslinked biodegradable hydrogels loaded with IL-2 are effective tools for local IL-2 therapy. Eur J Pharm Sci (2004) 0.86
Leprosy-specific B-cells within cellular infiltrates in active leprosy lesions. Hum Pathol (2007) 0.85
Stratum corneum cytokines and skin irritation response to sodium lauryl sulfate. Contact Dermatitis (2006) 0.85
Expression and function of B7-1 (CD80) and B7-2 (CD86) on human epidermal Langerhans cells. Eur J Immunol (1996) 0.85
Skin irritants and contact sensitizers induce Langerhans cell migration and maturation at irritant concentration. Exp Dermatol (2006) 0.85
Prognostic significance of peripheral blood CD8highCD57+ lymphocytes in bladder carcinoma patients after intravesical IL-2. Anticancer Res (2011) 0.84
Prediction of response in cancer immunotherapy. Anticancer Res (2011) 0.84
The HET-CAM, a Useful In Vitro Assay for Assessing the Eye Irritation Properties of Cosmetic Formulations and Ingredients. Toxicol In Vitro (1999) 0.84
M. leprae components induce nerve damage by complement activation: identification of lipoarabinomannan as the dominant complement activator. Acta Neuropathol (2015) 0.84
Effects of ultraviolet B radiation on human Langerhans cells: functional alteration of CD86 upregulation and induction of apoptotic cell death. J Invest Dermatol (1998) 0.83
A summary report of the COLIPA international validation study on alternatives to the draize rabbit eye irritation test. Toxicol In Vitro (2010) 0.83
Comparative in vitro-in vivo percutaneous penetration of the fungicide ortho-phenylphenol. Regul Toxicol Pharmacol (2002) 0.82
In vitro effects of ultraviolet B radiation on human Langerhans cell antigen-presenting function. Cell Immunol (1995) 0.81
Accumulation of low-avidity anti-melanocortin receptor 1 (anti-MC1R) CD8+ T cells in the lesional skin of a patient with melanoma-related depigmentation. Melanoma Res (2006) 0.81
Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation. J Pathol (2002) 0.81
Genetic polymorphism of metabolic enzymes modifies the risk of chronic solvent-induced encephalopathy. Toxicol Ind Health (2006) 0.80
Immortalization of human melanocytes does not alter the de novo properties of nitric oxide to induce cell detachment from extracellular matrix components via cGMP. In Vitro Cell Dev Biol Anim (2008) 0.79
In vitro primary sensitization and restimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans' cells. Immunology (1993) 0.79
In vitro primary sensitization of hapten-specific T cells by cultured human epidermal Langerhans cells--a screening predictive assay for contact sensitizers. Clin Exp Allergy (1996) 0.78
Serum testosterone plays an important role in the metastatic ability of castration resistant prostate cancer. World J Urol (2012) 0.78
Responsiveness of human monocyte-derived dendritic cells to thimerosal and mercury derivatives. Toxicol Appl Pharmacol (2010) 0.78
Assessment of contact allergens by dissociation of irritant and sensitizing properties. Toxicol In Vitro (2004) 0.78
Antigenic profiles of individual-matched pairs of primary and melanoma metastases. Hum Pathol (2009) 0.77
Changes in cytokine profile during local IL-2 therapy in cancer patients. Anticancer Res (2006) 0.77
UVB irradiation of normal human skin favors the development of type-2 T-cells in vivo and in primary dermal cell cultures. Photochem Photobiol (2002) 0.77
Multiple complementary transcripts of pCMa1, a novel gene located at chromosome 11p15.1-2, and melanocytic cell transformation. J Pathol (2002) 0.76
A two-centre evaluation of the human organotypic skin explant culture model for screening contact allergens. Altern Lab Anim (2003) 0.76
Intratumoural interleukin-2 therapy can induce regression of non-resectable mastocytoma in dogs. Anticancer Res (2013) 0.76
The Amiens Strategy: small phase III trials for clinically relevant progress in the war against cancer. J Clin Oncol (2009) 0.76
In vitro sensitization of human T cells with hapten-treated Langerhans cells: a screening test for the identification of contact allergens. Curr Probl Dermatol (1996) 0.76
Local interleukin-2 and interleukin-12 therapy of bovine ocular squamous cell carcinomas. Vet Immunol Immunopathol (2005) 0.75
Human in vitro T cell sensitization using hapten-modified epidermal Langerhans cells. Adv Exp Med Biol (1993) 0.75
An interlaboratory study of the reproducibility and relevance of Episkin, a reconstructed human epidermis, in the assessment of cosmetics irritancy. Toxicol In Vitro (1998) 0.75
Chemicals with weak skin sensitizing properties can be identified using low-density microarrays on immature dendritic cells. Toxicol Lett (2007) 0.75
Stimulation of cyclic GMP efflux in human melanocytes by hypergravity generated by centrifugal acceleration. Pigment Cell Res (2004) 0.75
In vitro determination of sunscreen immune protection factors. Arch Dermatol Res (2000) 0.75
Inhibitory effects of ultraviolet B on human Langerhans cell antigen presenting function. Adv Exp Med Biol (1995) 0.75
Non-lesional vitiliginous melanocytes are not characterized by an increased proneness to nitric oxide-induced apoptosis. Exp Dermatol (2005) 0.75
Follow-up to the ECVAM prevalidation study on in vitro tests for acute skin irritation. The European Centre for the Validation of Alternative Methods Skin Irritation Task Force report 2. Altern Lab Anim (2002) 0.75
Determination of sunscreen immune protection factors using human dendritic cell suspensions. Toxicol In Vitro (2004) 0.75
Gravity and cyclic GMP levels in melanocytic cells. J Gravit Physiol (2002) 0.75
cis-urocanic acid failed to affect in vitro human Langerhans cell allostimulatory function. Photochem Photobiol (1995) 0.75